CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.

Amid uncertainty for its vaccine division, CSL is growing the footprint of its bread-and-butter plasma therapies business by ...

(Reuters) -Australian biotech firm CSL said on Tuesday it would invest $1.5 billion in the U.S. to manufacture plasma-derived ...

Australia’s largest drugmaker CSL Ltd. is committing roughly $1.5 billion to expand its US manufacturing footprint, joining a ...

CSL Limited (CSLLY) stock rises as the company plans to invest $1.5B in U.S. to boost the production of plasma-derived ...

When people think of plasma donation centers the first things that come to mind are needles had helping others. Besides plasma donations being vital for people with organ transplants and hemophilia, ...

Plasma collection company CSL Plasma and its parent company CSL Behring have settled with the Illinois attorney general's office, resolving a lawsuit alleging the company’s policies discriminate ...

As global demand for plasma therapies rises, Australian plasma maker CSL said Wednesday it had agreed to acquire North Carolina-based Talecris Biotherapeutics Holdings for $3.1 billion, taking a ...

Feb. 27—Two Southern Oregon residents are suing CSL Plasma for millions of dollars, saying that their blood plasma donations in Medford caused them stints in the hospital lasting months and ...

CSL Ltd., an Australian maker of blood-plasma therapeutics, says it is exploring whether it can develop a plasma product to treat Ebola. Chief Executive Paul Perreault said he formed a small team to ...